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Abstract
Background: Despite numerous evidences for the positive effect of community pharmacists on health care,
interprofessional collaboration of pharmacists and general practitioners is very often limited. Though highly trained,
pharmacists remain an underutilised resource in primary health care in most western countries. This qualitative
study aims at investigating pharmacists’ and general practitioners’ views on barriers to interprofessional
collaboration in the German health care system.
Methods: A total of 13 narrative in-depth interviews, and two focus group discussions with 12 pharmacists and
general practitioners in Mecklenburg-Western Pomerania, a predominantly rural region of North-Eastern Germany, were
conducted. The interviews aimed at exploring general practitioners’ and pharmacists’ attitudes, views and experiences
of interprofessional collaboration. At a second stage, two focus group discussions were performed. Fieldwork was
carried out by a multi-professional team. All interviews and focus group discussions were audio taped and transcribed
verbatim. The constant comparative method of analysis from grounded theory was applied to the data.
Results: There are three main findings: First, mutual trust and appreciation appear to be important factors influencing
the quality of interprofessional collaboration. Second, in light of negative personal experiences, pharmacists call for a
predefined, clear and straightforward way to communicate with physicians. Third, given the increasing challenge to
treat a rising number of elderly patients with chronic conditions, general practitioners desire competent support of
experienced pharmacists.
Conclusions: On the ground of methodological triangulation the findings of this study go beyond previous
investigations and are able to provide specific recommendations for future interprofessional collaboration. First,
interventions and initiatives should focus on increasing trust, e.g. by implementing multi-professional local quality
circles. Second, governments and health authorities in most countries have been and still are reluctant in advancing
political initiatives that bring together physicians and pharmacists. Proactive lobbying and empowerment of
pharmacists are extremely important in this context. In addition, future physician and pharmaceutical training curricula
should focus on comprehensive pharmacist-physician interaction at early stages within both professional educations
and careers. Developing and fostering a culture of continued professional exchange and appreciation is one major
challenge of future policy and research.
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Background
Along with demographic and epidemiological changes a
growing number of patients with multiple chronic dis-
eases need to be cared for. In primary care, general practi-
tioners (GPs) across Europe, the US and Australia are
increasingly supported by other qualified health profes-
sions, such as nurse practitioners or practice nurses. Inter-
professional collaboration with community pharmacists,
though, did not develop to the same extent. In general,
GP-pharmacist interactions are of low frequency [1–3].
This is striking since numerous studies from various
settings provide evidence for the positive effect of com-
munity pharmacists on medication management, patient
counselling, health education, and improved care result-
ing in better clinical outcomes [4–6]. A recent Cochrane
Review shows that pharmacist interventions are particu-
larly beneficial for reducing systolic blood pressure, im-
proving HbA1C and blood glucose level, and for the
management of asthma [4].
However, interprofessional collaboration of pharma-
cists and GPs is very often limited to the clarification of
inaccurate prescriptions [3, 7] or the provision of drug-
related information [8]. For instance, Urban and colleagues
found that the potential of community pharmacists to im-
prove patient safety after discharge from hospital is not be-
ing used in England [9]. Across Europe pharmacists are
infrequently involved in patient-centred professional activ-
ities such as monitoring plans [10]. The situation in the US
differs to some extent as the implementation of collabora-
tive working relationships between community pharmacists
and physicians aims at fostering interprofessional collabor-
ation. Yet collaboration is often limited by compensation
barriers and a lack of initiative [11]. Though highly trained,
in most western countries pharmacists are in fact an under-
utilised resource within the primary health care sector [12].
First attempts to explain this development point to GPs’
concerns about an increasing workload and patient confu-
sion, as well as a different perception and importance
assigned to trust and communication [13, 14]. Ambler sus-
pects that existing barriers are highly related to the fact that
GPs and pharmacists do not know one another very well
[1]. In fact, a comprehensive understanding of the way GPs
and community pharmacists perceive the others pro-
fession, is still missing. The aim of this paper was to
investigate the views of pharmacists and GPs on bar-




This work is part of a pilot study that has been con-
ducted at Rostock University Medical Center, Germany.
Whereas the pilot study aimed at developing and testing
a focused localized intervention, this work pursued a
wider aim by addressing existing barriers to interprofes-
sional collaboration between GPs and pharmacists in the
German health care system. In Germany, most pharma-
cies are small-sized private enterprises mainly concerned
with drug disposal. Pharmacists usually provide basic
drug information; they are rarely involved in drug man-
agement. There is no public drug program providing
medication reviews or similar services.
In 2012/2013 we conducted narrative in-depth inter-
views and focus group discussions with community phar-
macists and GPs in Mecklenburg-Western Pomerania, a
predominantly rural region of North-eastern Germany.
The narrative interviews were carried out by CK and FB
(both young female physicians). Interviewers and inter-
viewees have not met each other before the interview.
First, seven GPs and six community pharmacists were
interviewed. The interviews aimed at exploring GPs’ and
pharmacists’ attitudes, views and experiences of interpro-
fessional collaboration. Narrative interviews have been
developed in the 1970s to stimulate memory and narra-
tion. They aim at motivating interviewees to narrate ex-
tensively about self-experienced events and to reconstruct
courses of action and ex-post evaluations [15]. Narrative
interviews are characterized by an initial phase of topic
formulation, which is carried out by the interviewer. The
initial phase is followed by the main narrative phase of the
interviewee, where the interviewer only takes notes. When
the interviewee stops talking, the interviewer refers to the
information gained so far and stimulates the interviewee
to narrate and describe further details. Then external
open-ended questions, formulated prior to the interview,
are asked [16]. External questions addressed to the phar-
macists included, for instance, positive and negative expe-
riences and situations of interprofessional collaboration
with GPs. Equally GPs were asked to report their experi-
ences with regard to collaborations with pharmacists. Sub-
sequent to each interview, the interviewer drafted a memo
to summarize the interview situation, the information
gained and first ideas for the analyses.
At a second stage, emerged perceptions, concepts and
potential solutions that arose from the interviews provided
the basis for possible localized interventions and were
reflected in the group discussions [17]. The major purpose
of the focus group discussions was to debate on feasibility
and acceptability of those potential interventional concepts
to improve interprofessional collaboration. Once having
completed interviews, we performed two focus group dis-
cussions with a total of eight GPs and four pharmacists. As
the interviews already provided insight into the potential
for conflict between both professions, the first focus group
discussion was performed with GPs only. Four GPs partici-
pated in this discussion. Potential interventional concepts
were modified after that discussion. Another four GPs and
four pharmacists took part in the second discussion. A
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team of two researchers, BS and CL (a male pharmacist
and a female sociologist) moderated the discussions and
encouraged participants to share their perceptions and
point of views, e.g. on advantages and disadvantages of dif-
ferent paths of communication. The questions raised were
based on previous findings from interviews. The interviews
had an average length of 30 min, the focus group discus-
sions lasted about 90 min each. Interviews were stopped as
soon as additional data collection did not provide any new
insights. During the focus group discussions, participants
extensively discussed and refined the interventional ele-
ments that emerged from the interviews. They also agreed
on potential procedures for interprofessional collaboration,
which were tested in a pilot study. This paper focuses on
pharmacists’ and GPs’ views on barriers to interprofes-
sional collaboration. It is not the intention of this work to
provide respondents evaluation of the proposed interven-
tions, which will be published elsewhere.
Interviewee recruitment and sample description
Community pharmacists were selected from a contact list
of local community pharmacists provided by the Chamber
of Pharmacists of Mecklenburg-Western Pomerania. A
total of 15 pharmacists, who participated in a previous
study on polypharmacy among elderly, were contacted via
mail. Ten of them agreed to take part. Six pharmacists
were interviewed and four pharmacists took part in the
focus group discussion. GPs were recruited through the
local teaching and research network of the Institute of
General Practice at the Rostock University Medical
Center. 40 GPs were randomly contacted by mail from
which 15 were interested. Seven GPs were interviewed
and eight GPs participated in the focus group discussions.
Thus, in total 25 interviewees participated in this qualita-
tive study. Two of the pharmacists were male and eight
were female; age ranged from 31 to 44 years. Among GPs
eight were male and seven female; age ranged from 37 to
75 years. Interviewees of both professions worked in
places with different levels of urbanisation, ranging from
rural to medium-sized and urban.
Data analyses
All interviews and focus group discussions were audio
taped and transcribed verbatim. Since the authors of this
paper belong to various disciplines, the analyses benefit-
ted from a multidisciplinary perspective: Additionally to
memos drafted right after the interviews and focus
group discussions, the authors drafted thematic memos
and discussed them regularly. We applied the constant
comparative method of analysis from grounded theory
[18–20] to the data by employing the three steps of cod-
ing and categorizing: open coding, axial coding, and se-
lective coding. Coding and categorising of the interviews
was done by CK and CL and discussed continuously
with the other researchers through the entire process of
analysing. This proceeding also increased coding reliabil-
ity. All data was managed and coded by using a qualita-
tive data software program (QSR NVivo version 9).
Presentation of findings
A number of categories turned out to influence pharma-
cists’ and GPs’ views on interprofessional collaboration.
These categories arose from both, the interviews and the
focus group discussions. As they are highly interwoven with
each other, findings are organized in a way to contrast phar-
macists’ with GPs’ points of view and experiences with
interprofessional collaboration. Relevant categories are
summarized and presented in Fig. 1. The quotes used to il-
lustrate our results were translated by a professional bilin-
gual translator. Information that would allow indirect
identification of interviewees or focus group participants
was removed.
Results
Interprofessional collaboration from the pharmacists’
point of view
The qualitative data material showed that the interviewed
community pharmacists felt competent and authorised to
solve pharmaceutical problems. They emphasised their
legal responsibility to take care of the medication provided
to patients. In doing so they wished for a stronger support
by the GPs. Almost all participating pharmacists saw a
need to improve the doctor-pharmacist dialog.
Community pharmacists reported that major occa-
sions requiring contact to GPs include contraindications,
drug interactions, and unclear prescriptions. Whereas
some of the participating pharmacists made, in general,
positive experiences when contacting GPs, the majority
stated to encounter recurring difficulties getting GPs on
the phone and receiving an answer to their query. Rather
than perceiving these queries as supportive, pharmacists
often had the feeling that GPs considered requests as in-
vasive and controlling. Further obstacles mentioned were
physicians’ time constraints and the non-cooperation of
nurses in connecting pharmacists and physicians on
phone. Several pharmacists reported about negative ex-
periences, malicious insults and a lack of respect when
contacting physicians. One female pharmacist talked
about the effect negative reactions of physicians have on
her work. When fearing verbal abuses she usually avoids
calling physicians and tries to raise patients’ awareness
of potential pharmaceutical problems:
“Sometimes we actually fear calling there, because we
are scared of being snapped at. You know, we’ve
sometimes had such bad experiences. Of course, we’ve
also had really good experiences, but you know, if you
have ten really good experiences and only one bad one
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it is the bad experience that sticks. […] So that is when
you get scared and say, “are you really going to call
him?” […] And if I end up telling myself, “God no, I’m
not even going to call him!”, then I try to somehow
sensitize the patient – at least a little, right? Or you
end up telling them, “why don’t you go back there and
ask him yourself one more time?”
Compared to pharmacists working in urban areas,
those employed in rural and provincial regions reported
less negative experiences when contacting GPs. They often
experienced long-lasting working relationships to local
physicians that were mostly characterized by mutual trust
and appreciation. With this foundation interprofessional
collaboration was more successful. In contrast, in cities
interprofessional collaboration was constrained by urban
anonymity: Quite often, pharmacists hardly knew the phy-
sicians they tried to contact. One pharmacist described
the situation when contacting unknown physicians:
“And of course, sometimes it’s those other doctors (GPs)
whose offices are located a bit further away and whom
you’re not constantly in touch with. That makes it
difficult to reach them or to carefully explain
something to them without giving them the feeling
that, well, how should I put it, you’re stepping on their
toes […]All that is always kind of tricky, that is, if you
can reach them at all.”
Being aware that, ultimately, physicians take decisions of
patient medication, most pharmacists expressed the desire
for a predefined, clear and straightforward way to commu-
nicate with physicians. They argued that a straightforward
communication would avoid wrong assumptions and mis-
understandings while aligning outcome-oriented physician-
pharmacist communication.
Interprofessional collaboration from GPs’ point of view
When asked about interprofessional collaboration with
pharmacists, initially most GPs did not report any diffi-
culties or obstacles. Some GPs - again primarily those
from rural and medium-sized areas - emphasised their
good relationships with local pharmacies. Most GPs re-
ported about occasional phone calls from community
pharmacies in case of unclear prescriptions. GPs gener-
ally appreciated this kind of safety net. However, only
few GPs stated to contact pharmacists on their own ini-
tiative. Major reason given was the lack of time.
Not until delving into the focus group discussions,
GPs questioned pharmacists’ active involvement into
therapeutic decision-making. GPs perceived themselves as
most capable and most responsible for patients’ medica-
tion. They felt that pharmacists miss background informa-
tion on patients’ medical history and/or professional
knowledge to understand and reconstruct physicians’ rea-
soning in many cases:
“And when there is something I’m not sure of and I
think to myself, “well, there used to be something, what
was it called again?”, then of course I call! But that’s
not the usual case, because pharmacists - well they
simply are not trained that way. Well, at least not in
terms of therapy. They are trained how to roll a pill
aren’t they? I can check the effects and the other
information right here on my own. I can assess
interactions, contraindications and all that with the
software I use. Those things have become a lot simpler
due to the software.”
In line with this, GPs clearly stated to appreciate
pharmaceutical involvement when it was clinically rele-
vant for the treatment of the patient. They emphasised
that only high professional education and experience
Fig. 1 Categories influencing GPs’ and pharmacists’ views on interprofessional collaboration
Löffler et al. BMC Health Services Research  (2017) 17:224 Page 4 of 7
qualifies community pharmacists to decide whether cer-
tain information would be relevant for GPs or not. The
benefit of receiving phone calls from “young, inexperi-
enced pharmacists pointing to relative contraindica-
tions” was questioned by interviewed GPs. They
underlined their desire for specific proposals to solve a
given pharmaceutical problem. During one focus group
discussion a GP stated, for instance, the following:
“[That is why] it is so very important [to know] who is
calling. Is it someone [clinically] experienced or
somebody who is just calling due to a “bing” on his
computer screen – those people tend to call the GP,
too. It does, of course, play a role who approaches you.
[…] What I mean is, that we should immediately find
a solution [in regard to the problematic prescription].
And then, when we do, to also find some kind of
practical way to use that information.”
In the same vein, another GP reported to feel stressed
by those pharmacists just calling him without boiling in-
formation down to the essence. He finally enforced the
rule that merely two experienced pharmacists of this
pharmacy were allowed to contact him:
“At the pharmacy next door there are two pharmacists,
when they call, it instantly sets my teeth on edge. When
they start rambling I always tell them “make it short, I
have no time”. This of course leaves them dumbfounded,
trying to remember what they were actually calling
about and eventually they hang up because they just
can’t stay focussed. (…) I simply don’t have the time to
listen to some pharmacist’s gibberish. And I have to
admit that I only know pharmacists who have plenty of
time – in contrast to us. […] I have now established that
while the chief pharmacist and maybe even the new
colleague may call me, the others simply aren’t allowed
to call me at all; because I know they’ll end up yapping
forever without being able to make it short.”
In light of a rising number of patients with chronic
diseases and multimorbidity, time pressure was a major
topic in the interviews and focus group discussions. GPs
felt challenged in means of treating these patients under
time constraints and avoiding or limiting polypharmacy.
Most physicians perceived that community pharmacists
were not able to respond to this challenge. Quite the
contrary, some GPs thought that pharmacists would
have their own agenda by making money with exactly
this group of patients:
“The problem is that pharmacies are promoting
exactly this [the medicalization]. They sell blood-
glucose-meters and, if they could, they would sell
cholesterol testing devices and all kind of other stuff.
It is them making people nervous. They even
perform some kind of pseudo-venography.
Osteoporosis-assessment, cholesterol-measurement,
all of that just fuels the fire. While they want to
sell more medication, we [the GPs] share a
common interest to use less. At least I see it that
way, and that’s just one more issue at hand, you
know, that we have diverging interests.”
Discussion
By employing in-depth interviews and focus group discus-
sions this qualitative study explores how German GPs and
community pharmacists perceive both their interprofes-
sional collaboration as well as the profession of the other.
There are three principal findings: First, mutual trust
and appreciation - most prevalent among GPs and phar-
macists from rural and medium-sized locations - appear
to be important factors influencing the quality of inter-
professional collaboration. There is evidence that ano-
nymity strongly hampers the interaction between GP
and pharmacist, whereas grown trust facilitates collabor-
ation. Second, in light of negative personal experiences,
pharmacists call for a predefined, clear, and straightfor-
ward way to communicate with physicians. In their view,
such a communication frame would be able to strengthen
interprofessional collaboration. This is also important with
respect to GPs lack of time. Third, with regard to the ris-
ing number of elderly patients with chronic conditions,
GPs desire competent straightforward support of experi-
enced pharmacists. In light of the current pharmaceutical
education and training also experts have emphasised that
most German pharmacists lack clinical knowledge and ex-
periences [21]. Actually, GPs perceived that pharmacists
would have divergent interests by making money, espe-
cially with elderly patients suffering from chronic diseases.
The qualitative data provides evidence that based on
negative experiences some community pharmacists
avoid interprofessional contact and delegate responsibil-
ity for patient safety to the patient him-/herself. Patients,
however, might not be able to evaluate the seriousness
of the information gained. Non-communication might
result in avoidable (serious) adverse events.
A previous survey conducted in Eastern Germany and
investigating perceptions of pharmacists and physicians
found that there is a foundation for a functional rela-
tionship between both professions in this setting [3].
Nonetheless, collaboration is of low frequency. Our
study is the first that provides in-depth insights into
existing barriers that are responsible for a low level of
interprofessional interaction in this area. Focusing on
different settings, some other qualitative studies analysed
collaboration of community pharmacists and physicians.
In New Zealand, Hatah and colleagues found that GPs
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fear patient confusion and increasing workload when in-
volving pharmacists into patient counselling [13].
Though mentioned, these aspects were of minor import-
ance in our setting. Bradley and colleagues concluded
for England that factors such as trust, communication,
professional respect and “knowing” each other were key
components of collaboration [14]. This is in line with
our findings from North-Eastern Germany.
Actually, the model of collaborative working relation-
ships (CWR) that is used as theoretical framework in a
number of quantitative studies investigating physician-
pharmacist collaboration assumes that there are five pro-
gressive stages of collaboration: Starting with professional
awareness progressing to professional recognition, explor-
ation and trial, professional relationship expansion and fi-
nally commitment [22]. According to a survey with 239
Iowa pharmacists conducted by Liu and Doucette pharma-
cists need to show their skills and knowledge to physicians
and clarify each party’s responsibilities in the care process
in order to start collaboration [23]. Van et al. [24] also
underlined the importance of early contact and proximity.
Most qualitative studies addressing physician-pharmacist
collaboration make use of qualitative interviewing exclu-
sively [2, 13, 14]. Focus group discussions or the triangula-
tion of qualitative methods are rarely used [12]. The
analyses of narrative in-depth interviews and focus group
discussions in this study provide evidence, that the triangu-
lation of methods is highly desirable when investigating
this topic. Only during the focus group discussions, GPs
and pharmacists started a dynamic discussion on experi-
ences and provided numerous examples of failed collabor-
ation. Qualitative interviews only, would not have provided
these in-depth insights. The findings of this study go, in
fact, beyond previous investigations and are able to provide
specific recommendations for future interprofessional col-
laboration. Alongside with triangulation of qualitative
methods, our study benefitted from a multidisciplinary per-
spective including several scientific backgrounds and pro-
fessions. Nonetheless, the hypotheses generated in the
context of rural Mecklenburg-Western Pomerania, do not
necessarily have to be valid for other settings. In addition,
confirmatory studies, such as a representative cross-
sectional study, or a pilot study addressing current barriers,
are necessary to further validate findings.
However, our findings have implications for policy
makers and stakeholders. Existing barriers for pharmacist-
physician interaction include a low level of mutual trust
and appreciation, a missing framework for interprofes-
sional communication, and the discordance about the im-
portance of different pharmaceutical information. To
improve interprofessional collaboration, firstly, interven-
tions and initiatives should focus on increasing trust and
appreciation. Obviously, doing so is much more difficult
in urban areas than in rural regions. Local quality circles
(periodic meetings of GPs) might be a good occasion to
bring together both professions. Niquille and colleagues
showed that in Switzerland physician-pharmacist quality
circles were able to increase collaboration. Interestingly,
compared to a control group among these circles drug
costs were reduced by 42% [25]. Also, campaigns support-
ing pharmacists to introduce themselves and their phar-
macies to local GPs might be discussed. Secondly, in most
countries governments and health authorities have been
and still are reluctant in advancing political initiatives that
join physicians and pharmacists. Proactive lobbying [26]
and empowerment of pharmacists are extremely import-
ant. Meanwhile, stakeholders should elaborate and pro-
vide recommendations for effective communication of
pharmacists with physicians. Last, but not least, future
physician and pharmaceutical-training curricula should
focus on comprehensive pharmacist-physician interaction.
Gallagher and Gallagher called for inter-professional and
multi-professional learning opportunities at early stages
within both professional educations. Different models
have been developed in Scotland and the UK [26]. Devel-
oping and fostering a culture of continued professional ex-
change and appreciation is one major challenge of future
policy and research.
Conclusion
This qualitative study explores the perception GPs and
community pharmacists have of their own profession as
well as their perception of interprofessional collaboration.
The data shows that there are three main barriers hamper-
ing physician-pharmacist interaction: First, a lack of
mutual trust and appreciation, second an insufficiency of
pre-defined communication structures and third, discord-
ance about the importance of pharmaceutical information
for patient care and treatment. Future initiatives and re-
search should focus on developing, advancing and evaluat-
ing approaches to overcome these barriers and to increase
interprofessional collaboration.
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